Plus Therapeutics Expands Strategic Agreement with Telix IsoTherapeutics Group for Rhenium-186 Radioisotope Supply
December 3, 2024
Eiger BioPharmaceuticals Announces Presentation of Positive Phase 2 Results of Avexitide in Congenital Hyperinsulinism at the American Diabetes Association Virtual 81st Scientific Session
June 28, 2021
Related Post
-
-
Ainos, Inc. Announces Strategic Partnership with Taiwan Tanabe Seiyaku to Advance Manufacturing and Taiwan Market Promotion of Sjögren’s Syndrome Drug
December 2, 2024
-
TransCode Therapeutics, Inc. Announces $8 Million Private Placement
November 27, 2024
-
Greenwich LifeSciences Partners with GIM in Italy
November 26, 2024